Citius Pharmaceutical, CTXR, Biotech Stock Review

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the Biotech Stock...

Citius Pharma (CTXR) Corporate Presentation (Jan 2020).

In the above graphic, the catheter can get infected by bacteria and most typically see evidence of the infection (see gross graphic below) at...
Mitesco, Biotech Stock Review

Medtech Incubator True Nature | Mitesco (TNTY) Adds Another Heavy Hitter to Board.

True Nature Holding, Inc. DBA Mitesco, Inc. Adds Distinguished Healthcare Executive to Board of Directors. ATLANTA, GA, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via...
Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive and board member with more than 25 years of success spanning healthcare, technology, education and retail....

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy. The big picture concept at...
steven boyd, biotech stock review

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

April 2019 Offering On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors for the sale by us of...

Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.

The five-year project aims to support consumer-centered care and patient engagement technology use. PatientEngagementHIT.com "Project leaders will focus on making healthcare more convenient and accessible to...
Mitesco, Biotech Stock Review

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic Notes.

This is a Welcome Step in the Right Direction. ATLANTA, GA, Nov. 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OTCQB:...
True Nature, Mitesco, Biotech Stock Review

Is True Nature (TNTY) $0.04, Nearing a Breakout?

After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible Breakout. Only time...
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders. "Been there, done that -...

Latest article

Annette L. Redmond Joins Strategic Advisory Board at Sekur Private Data (SWISF).

Former U.S. State Department Deputy Assistant Secretary Decorated intelligence and cybersecurity executive with four decades of U.S. government leadership joins Sekur to advise on secure...

10X Alerts: Sekur Private Data (SWISF) Pushes SekurOne Closer to Market With First International...

Sekur has completed its first domestic and international encrypted calls on SekurOne and launched the platform’s voice, email, messenger, and VPN capabilities on Android...

Could a Record El Niño Ignite the Next Vaccine Trade?

Chikungunya, Dengue Fever, Rift Valley Fever and Zika The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks? Investors obsess over interest rates, tariffs and AI....